| Product Code: ETC11704782 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Daratumumab Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Daratumumab Market Revenues & Volume, 2021 & 2031F |
3.3 India Daratumumab Market - Industry Life Cycle |
3.4 India Daratumumab Market - Porter's Five Forces |
3.5 India Daratumumab Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Daratumumab Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 India Daratumumab Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Daratumumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Daratumumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multiple myeloma in India |
4.2.2 Growing awareness and adoption of innovative therapies |
4.2.3 Favorable government policies supporting cancer treatment |
4.3 Market Restraints |
4.3.1 High cost associated with daratumumab treatment |
4.3.2 Limited access to specialized healthcare facilities in certain regions |
5 India Daratumumab Market Trends |
6 India Daratumumab Market, By Types |
6.1 India Daratumumab Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Daratumumab Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 India Daratumumab Market Revenues & Volume, By Injectable Daratumumab, 2021 - 2031F |
6.1.4 India Daratumumab Market Revenues & Volume, By Daratumumab Biosimilar, 2021 - 2031F |
6.1.5 India Daratumumab Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.1.6 India Daratumumab Market Revenues & Volume, By Oral Daratumumab, 2021 - 2031F |
6.2 India Daratumumab Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 India Daratumumab Market Revenues & Volume, By Monoclonal Antibody, 2021 - 2031F |
6.2.3 India Daratumumab Market Revenues & Volume, By Biosimilar Technology, 2021 - 2031F |
6.2.4 India Daratumumab Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.5 India Daratumumab Market Revenues & Volume, By Oral Drug Delivery, 2021 - 2031F |
6.3 India Daratumumab Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Daratumumab Market Revenues & Volume, By Oncologists, 2021 - 2031F |
6.3.3 India Daratumumab Market Revenues & Volume, By Healthcare Providers, 2021 - 2031F |
6.3.4 India Daratumumab Market Revenues & Volume, By Cancer Patients, 2021 - 2031F |
6.3.5 India Daratumumab Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.4 India Daratumumab Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Daratumumab Market Revenues & Volume, By Multiple Myeloma Treatment, 2021 - 2031F |
6.4.3 India Daratumumab Market Revenues & Volume, By Cancer Therapy, 2021 - 2031F |
6.4.4 India Daratumumab Market Revenues & Volume, By Co-Therapy with Chemotherapy, 2021 - 2031F |
6.4.5 India Daratumumab Market Revenues & Volume, By Advanced Myeloma Care, 2021 - 2031F |
7 India Daratumumab Market Import-Export Trade Statistics |
7.1 India Daratumumab Market Export to Major Countries |
7.2 India Daratumumab Market Imports from Major Countries |
8 India Daratumumab Market Key Performance Indicators |
8.1 Patient survival rates post daratumumab treatment |
8.2 Number of new clinical trials and research studies on daratumumab in India |
8.3 Adoption rate of daratumumab in different regions of India |
8.4 Patient satisfaction and quality of life improvements post daratumumab treatment |
8.5 Number of collaborations and partnerships for daratumumab distribution and accessibility in India |
9 India Daratumumab Market - Opportunity Assessment |
9.1 India Daratumumab Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Daratumumab Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 India Daratumumab Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Daratumumab Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Daratumumab Market - Competitive Landscape |
10.1 India Daratumumab Market Revenue Share, By Companies, 2024 |
10.2 India Daratumumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here